Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 198

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The use of hybrid hybridomas to target human cytotoxic T lymphocytes

Lanzavecchia, Antonio, Scheidegger, Doris · 1987 · European Journal of Immunology

Abstract

This study describes a general strategy to produce hybrid monoclonal antibodies that are capable of targeting human cytotoxic T lymphocytes (CTL) against any cell carrying the appropriate target antigen. This is done by fusing a HAT‐sensitive, G418‐resistant anti‐T3 hybridoma with immune spleen cells (or with other hybridomas) that produce antibodies against the desired target antigen. In the hybrid hybridomas the reassortment of Ig heavy and light chains results in the production of bifunctional antibody molecules. Because of their double specificity, these antibodies are able to bridge human CTL to target cells and trigger cytotoxic function. We have isolated several stable hybrid hybridomas in which one specificity is against T3 and one either against HLA antigens (class II, DC‐1, A3), human Ig (IgM, IgE, x), Toxoplasma gondii or an ovary carcinoma‐associated antigen. In all of these cases we show that culture supernatants can efficiently and specifically target any CTL clone against any target cell that possesses the relevant surface antigen recognized by the antibody. Furthermore, the killing requires as little as 0.1 ng/ml of antibody, occurs at effector to target ratios comparable to those used in conventional cytotoxic assays and does not affect bystander cells. Nonspecific killing of Fc receptor‐positive cells can be avoided using F(ab′)2 fragments. As an example, we show that it is possible to (a) change the major histocompatibility complex class and allospecificity of a CTL clone and (b) target CTL against non‐major histocompatibility complex antigens such as Ig, parasites and tumor‐associated antigens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.1830170118

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 198

Metadata

Authors
Lanzavecchia, A., & Scheidegger, D.
Venue
European Journal of Immunology
Publisher
Wiley
Published
1987-01
Volume
17
Issue
1
Pages
105-111
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2110544075
Cited by
198
References
1
FWCI
22.51
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The use of hybrid hybridomas to target human cytotoxic T lymphocytes. https://app.cochat.ai/papers/10.1002/eji.1830170118
The paper
Lanzavecchia, A., & Scheidegger, D. (1987). The use of hybrid hybridomas to target human cytotoxic T lymphocytes. European Journal of Immunology. https://doi.org/10.1002/eji.1830170118

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.